Literature DB >> 19428854

Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria.

M M Pérez1, A Prenafeta, J Valle, J Penadés, C Rota, C Solano, J Marco, M J Grilló, I Lasa, J M Irache, T Maira-Litran, J Jiménez-Barbero, L Costa, G B Pier, D de Andrés, B Amorena.   

Abstract

Staphylococcus aureus vaccines based on bacterins surrounded by slime, surface polysaccharides coupled to protein carriers and polysaccharides embedded in liposomes administered together with non-biofilm bacterins confer protection against mastitis. However, it remains unknown whether protective antibodies are directed to slime-associated known exopolysaccharides and could be produced in the absence of bacterin immunizations. Here, a sheep mastitis vaccination study was carried out using bacterins, crude bacterial extracts or a purified exopolysaccharide from biofilm bacteria delivered in different vehicles. This polysaccharide reacted specifically with antibodies to poly-N-acetyl-beta-1,6-glucosamine (PNAG) and not with antibodies to other capsular antigens or bacterial components. Following intra-mammary challenge with biofilm-producing bacteria, antibody production against the polysaccharide, milk bacterial counts and mastitis lesions were determined. Bacterins from strong biofilm-producing bacteria triggered the highest production of antibodies to PNAG and conferred the highest protection against infection and mastitis, compared with weak biofilm-producing bacteria and non-cellular inocula. Thus, bacterins from strong biofilm bacteria, rather than purified polysaccharide, are proposed as a cost-efficient vaccination against S. aureus ruminant mastitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428854      PMCID: PMC3024585          DOI: 10.1016/j.vaccine.2009.02.005

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  46 in total

1.  Mutation of sarA in Staphylococcus aureus limits biofilm formation.

Authors:  Karen E Beenken; Jon S Blevins; Mark S Smeltzer
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties.

Authors:  G García del Barrio; F J Novo; J M Irache
Journal:  J Control Release       Date:  2003-01-09       Impact factor: 9.776

3.  Bap, a Staphylococcus aureus surface protein involved in biofilm formation.

Authors:  C Cucarella; C Solano; J Valle; B Amorena; I Lasa ; J R Penadés
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

4.  Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen.

Authors:  D McKenney; K L Pouliot; Y Wang; V Murthy; M Ulrich; G Döring; J C Lee; D A Goldmann; G B Pier
Journal:  Science       Date:  1999-05-28       Impact factor: 47.728

5.  Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle.

Authors:  T Tollersrud; L Zernichow; S R Andersen; K Kenny; A Lund
Journal:  Vaccine       Date:  2001-07-16       Impact factor: 3.641

6.  Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States.

Authors:  T Tollersrud; K Kenny; A J Reitz; J C Lee
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

7.  Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR.

Authors:  Kimberly K Jefferson; Sarah E Cramton; Friedrich Götz; Gerald B Pier
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

8.  SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus.

Authors:  Jaione Valle; Alejandro Toledo-Arana; Carmen Berasain; Jean-Marc Ghigo; Beatriz Amorena; José R Penadés; Iñigo Lasa
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

9.  Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. I. Challenge trials.

Authors:  Gabriel Leitner; Evgenia Lubashevsky; Anita Glickman; Marta Winkler; Arthur Saran; Zeev Trainin
Journal:  Vet Immunol Immunopathol       Date:  2003-05-30       Impact factor: 2.046

10.  Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide.

Authors:  Tomás Maira-Litrán; Andrea Kropec; C Abeygunawardana; Joseph Joyce; George Mark; Donald A Goldmann; Gerald B Pier
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  17 in total

Review 1.  The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG.

Authors:  David Skurnik; Colette Cywes-Bentley; Gerald B Pier
Journal:  Expert Rev Vaccines       Date:  2016-03-16       Impact factor: 5.217

Review 2.  [Bacterial biofilms: their importance in animal health and public health].

Authors:  Yannick D N Tremblay; Skander Hathroubi; Mario Jacques
Journal:  Can J Vet Res       Date:  2014-04       Impact factor: 1.310

3.  Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit.

Authors:  Raza A; Muhammad G; Rahman S U; Rashid I; Hanif K; Atta A; Sharif S
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

4.  Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection.

Authors:  Carmen Gil; Cristina Solano; Saioa Burgui; Cristina Latasa; Begoña García; Alejandro Toledo-Arana; Iñigo Lasa; Jaione Valle
Journal:  Infect Immun       Date:  2013-12-16       Impact factor: 3.441

5.  An extracellular Staphylococcus epidermidis polysaccharide: relation to Polysaccharide Intercellular Adhesin and its implication in phagocytosis.

Authors:  Anastasia I Spiliopoulou; Maria I Krevvata; Fevronia Kolonitsiou; Llinos G Harris; Thomas S Wilkinson; Angharad P Davies; Georgios O Dimitracopoulos; Nikos K Karamanos; Dietrich Mack; Evangelos D Anastassiou
Journal:  BMC Microbiol       Date:  2012-05-17       Impact factor: 3.605

Review 6.  Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.

Authors:  Janette M Harro; Brian M Peters; Graeme A O'May; Nathan Archer; Patrick Kerns; Ranjani Prabhakara; Mark E Shirtliff
Journal:  FEMS Immunol Med Microbiol       Date:  2010-05-29

7.  Efficacy of a polyvalent mastitis vaccine against Staphylococcus aureus on a dairy Mediterranean buffalo farm: results of two clinical field trials.

Authors:  Jacopo Guccione; Antonella Pesce; Massimo Pascale; Caterina Salzano; Gianni Tedeschi; Luigi D'Andrea; Angela De Rosa; Paolo Ciaramella
Journal:  BMC Vet Res       Date:  2017-01-19       Impact factor: 2.741

8.  Intramammary Immunisation Provides Short Term Protection Against Mannheimia haemolytica Mastitis in Sheep.

Authors:  Riccardo Tassi; Martina Schiavo; Joel Filipe; Helen Todd; David Ewing; Keith T Ballingall
Journal:  Front Vet Sci       Date:  2021-06-10

9.  Vaccines Directed Against Microorganisms or Their Products Present During Biofilm Lifestyle: Can We Make a Translation as a Broad Biological Model to Tuberculosis?

Authors:  Mario A Flores-Valdez
Journal:  Front Microbiol       Date:  2016-01-21       Impact factor: 5.640

10.  Vaccination against Staphylococcus aureus mastitis in two Swedish dairy herds.

Authors:  Håkan Landin; Marie Jansson Mörk; Maria Larsson; Karin Persson Waller
Journal:  Acta Vet Scand       Date:  2015-11-25       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.